Anatomy of a Breakthrough
Sometimes a doctor changes a patient's life by offering a new therapy when all else fails. Watch Karen's journey with Damon Runyon alum Jedd D. Wolchok, MD, PhD, from when she was diagnosed with melanoma to entering the immunotherapy clinical trial that cured her.
Our Mission
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. Since its founding in 1946, Damon Runyon has invested nearly $355 million and funded nearly 3,700 young scientists.
Behind the breakthroughs
Damon Runyon scientists recently shared their research on cutting-edge cancer therapies for melanoma and prostrate cancer patients that are saving lives. Watch Nobel Laureate Harold E. Varmus, MD, moderate the discussion with Jedd D. Wolchok, MD, PhD, and Christopher E. Barbieri, MD, PhD, as they give an inside perspective on the latest breakthroughs.
YUNG S. LIE, PHD, NAMED DAMON RUNYON'S NEXT LEADER
Yung S. Lie, PhD, was appointed the incoming President and Chief Executive Officer of the Damon Runyon Cancer Research Foundation. Dr. Lie succeeds Lorraine W. Egan, who will step down in December. Read about Dr. Lie, a former Damon Runyon fellow, as she leads our efforts to end cancer.
